Loading…
← CockpitCompetitor Analysis › 2291.HK LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class HOpen in the cockpit ↗

LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H2291.HKCompetitor analysis, valuation and peers

Hong Kong · HKD·Industrials›Miscellaneous Commercial Services
Momentum leader 88
Mkt cap
$574M
US dollars, full cap
Free float
22%
of shares outstanding
$/day
$526,416
20-day average traded
Fwd P/E
10.9×
forward earnings
ROIC−WACC
+18.5 pp
WACC 5.6%
Hurdle
-38 pp
Req g minus delivered
Next earnings
128 days
26 Mar 2027
Close · HKDHK$13.20
1D-1.4%
1W-12.0%
1M-3.4%
3M+15.7%
6M+9.9%
YTD-17.9%
1Y-30.5%
ATR %5.9%
52w lowhigh32.3% off high

What LEPU ScienTech Medical Technology (Shanghai) does

Employees: 370

LEPU ScienTech Medical Technology (Shanghai) at a glance

Size LEPU ScienTech Medical Technology (Shanghai) (2291.HK) is a Hong Kong Industrials company (Miscellaneous Commercial Services) with a market value of $574M, the 716th largest of 885 Hong Kong companies the cockpit tracks. Shares closed at HK$13.20 on 18 Nov 2026.

Performance Over six months the shares gained 9.9%, against -23.4% for the median peer and -14.0% for the Hong Kong market (cap-weighted) — 6th highest of 21 in its peer set.

Growth Revenue fell 4.2% over the last twelve months (peer median +7.7%); the operating margin is 42.0% (peer median 4.5%).

Valuation It trades at 10.9× forward earnings against a peer median of 14.7× (2nd cheapest of 12).

Price implies For today's price to make sense, revenue must grow about -10% a year for seven years (Req g). Recent delivered growth is +28%, so the hurdle is -38 pp: the price already allows for a slowdown.

Capital Return on invested capital runs 18.5 points above its cost of capital (5.6% WACC).

Next results Next results expected around 26 Mar 2027 (exchange calendar; dates can move).

Relative performance

8010012021 May 202621 Aug 202618 Nov 20262291.HK 107Peer median 77
Six months, rebased to 100: LEPU ScienTech Medical Technology (Shanghai) against the median of its 20 peers (local-currency closes).

LEPU ScienTech Medical Technology (Shanghai) financials

Reported figures in HKD; fiscal year ends 2025-12-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
RevenueHK$571MHK$573MHK$511MHK$361MHK$288M
Revenue growth—+12%+42%+25%—
Gross profitHK$460MHK$476MHK$453MHK$313MHK$252M
EBITDAHK$278MHK$298MHK$291MHK$173MHK$119M
Net incomeHK$230MHK$260MHK$266MHK$167M-HK$23.0M
Free cash flowHK$178MHK$162MHK$158MHK$85.6MHK$61.7M
Capital expenditureHK$58.3MHK$82.9MHK$92.6MHK$108MHK$96.9M
Total debtn/aHK$1.91MHK$3.80MHK$2.58MHK$3.74M

Quarterly statements and history in the cockpit →

LEPU ScienTech Medical Technology (Shanghai) competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-50%-25%0%+25%-20%-10%0%POSTI301468602721926146300197300149603018IEG300215300355PAY3011726030603625603007301365FMSIS2291.HK6-month return →1-month return →
Up and to the right = strong over both horizons. LEPU ScienTech Medical Technology (Shanghai) is the large dot.

Fundamentals: revenue growth against valuation

0%+20%+40%20×40×60×POSTI301468602721926146603018PAY603060FMSIS2291.HKRevenue growth (TTM) →Forward P/E →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. LEPU ScienTech Medical Technology (Shanghai) is the large dot.

Capital: growth delivered against growth the price implies

-20%0%+20%+40%+60%-25%0%25%50%POSTI602721926146300197300149603018IEG300215300355PAY301172603060301365FMSIS2291.HKGrowth delivered (Del g) →Growth the price implies (Req g, 7 yrs) →
Above the diagonal = the price needs more growth than the company has been delivering; below = the price already allows for a slowdown. LEPU ScienTech Medical Technology (Shanghai) is the large dot.

LEPU ScienTech Medical Technology (Shanghai) competitors and peer comparison

How LEPU ScienTech Medical Technology (Shanghai) compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

LEPU ScienTech Medical Technology (Shanghai) against its 20 peers (data as of 18 Nov 2026)
Measure2291.HKPeer medianRank in peer set
1-month return-3.4%-9.2%6th highest of 21
6-month return+9.9%-23.4%6th highest of 21
Distance from 52-week high-32.3%-43.4%8th highest of 21
Revenue growth (TTM)-4.2%+7.7%4th lowest of 21
Operating margin42.0%4.5%highest of 21
Forward P/E10.9×14.7×2nd cheapest of 12
Growth the price implies (Req g, 7 yrs)-9.6%6.8%2nd least demanding of 17
Growth delivered (Del g)+28.0%+5.7%3rd highest of 17
Hurdle (Req g minus delivered)-37.6 pp-3.3 pp2nd least demanding of 17
ROIC minus cost of capital+18.5 pp-0.7 pp3rd highest of 21
EV / EBITDA10.8×6.4×2nd most expensive of 8
Net debt / EBITDA-5.3×0.6×2nd least indebted of 9

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginForward P/EReq gDelivered g
LEPU ScienTech Medical Technology (Shanghai) 2291.HKHong Kong$574M+10%-4%42%10.9×-9.6%+28.0%
Posti POSTI.HEFinland$575M+39%0%5%14.7×-4.1%-1.4%
Pourin Special Welding Technology 301468.SZChina$577M-41%-4%5%61.5×n/an/a
Bengo4.com 6027.TJapan$571M+51%+22%14%43.2×14.6%+25.1%
Medlive Technology 2192.HKHong Kong$579M-22%+6%29%11.8×-3.3%+23.8%
Sporton International 6146.TWOTaiwan$580M-13%+8%30%14.3×-7.7%+5.0%
CECEP Techand Ecology and Environment 300197.SZChina$568M+11%+21%-271%n/a29.1%-26.5%
ChemPartner PharmaTech 300149.SZChina$582M-17%+18%2%n/a23.6%-5.2%
China Design 603018.SSChina$582M-24%-8%7%14.7×-9.0%-5.1%
Italian Exhibition IEG.MIItaly$582M+33%+4%18%15.4×-2.4%+28.4%
Suzhou Electrical Apparatus Science Academy 300215.SZChina$566M-41%+8%9%n/a6.9%-4.9%
M-Grass Ecology And Environment (Group) 300355.SZChina$565M-33%-23%-13%n/a11.0%+0.5%
PayPoint PAY.LUnited Kingdom$564M+26%+8%21%9.2×-15.9%+21.4%
Sichuan Joyou Digital Technologies 301172.SZChina$563M-45%+18%4%n/a57.6%+6.3%
China Testing & Certification International 603060.SSChina$563M-27%-6%4%29.2×11.3%+12.1%
Shanghai FourSemi Semiconductor 3625.HKHong Kong$562M-66%+3%-16%n/an/an/a
Danyang Syngen Intelligent Technology 603007.SSChina$591M-55%+298%-29%n/an/an/a
Matrix Design 301365.SZChina$593M-42%+9%4%n/a26.1%+3.6%
Fiera Milano FM.MIItaly$593M-13%+46%22%14.7×-5.0%+38.8%
Shenzhen Longtech Smart Control 300916.SZChina$595M-25%-2%3%n/an/an/a
SIS SIS.NSIndia$554M-9%+28%3%12.5×6.7%+11.9%

Questions

Which companies are LEPU ScienTech Medical Technology (Shanghai)'s closest peers?
The cockpit's peer set: Posti (POSTI.HE), Pourin Special Welding Technology (301468.SZ), Bengo4.com (6027.T), Medlive Technology (2192.HK), Sporton International (6146.TWO), CECEP Techand Ecology and Environment (300197.SZ), ChemPartner PharmaTech (300149.SZ), China Design (603018.SS).
Is LEPU ScienTech Medical Technology (Shanghai) expensive compared with its peers?
On forward p/e it trades at 10.9× against a peer median of 14.7×, 2nd cheapest of 12 in its peer set. For today's price to make sense, revenue must grow about -10% a year for seven years (Req g). Recent delivered growth is +28%, so the hurdle is -38 pp: the price already allows for a slowdown.
How has LEPU ScienTech Medical Technology (Shanghai) stock performed?
Over six months to 18 Nov 2026 the shares returned +9.9% against -23.4% for the median peer; over one year -30.5%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.